WallStreetZenWallStreetZen

NYSE: NUS
Nu Skin Enterprises Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NUS

Based on 1 analyst offering 12 month price targets for Nu Skin Enterprises Inc

Min Forecast
$7.00+26.35%
Avg Forecast
$7.00+26.35%
Max Forecast
$7.00+26.35%

Should I buy or sell NUS stock?

Based on 1 analyst offering ratings for Nu Skin Enterprises Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their NUS stock forecasts and price targets.

NUS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-12-20

1 of 1

Forecast return on equity

Is NUS forecast to generate an efficient return?

Company
5.72%
Industry
146.64%
Market
75.61%
NUS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NUS forecast to generate an efficient return on assets?

Company
2.54%
Industry
13.64%
NUS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NUS earnings per share forecast

What is NUS's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$1.10
Avg 2 year Forecast
$0.75

NUS revenue forecast

What is NUS's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$1.6B-7.41%
Avg 2 year Forecast
$1.7B-4.23%
NUS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NUS revenue growth forecast

How is NUS forecast to perform vs Household & Personal Products companies and vs the US market?

Company
-7.41%
Industry
1.09%
Market
58.64%
NUS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NUS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NUS vs Household & Personal Product Stocks

TickerPricePrice TargetUp/downsideConsensus
NUS$5.54$7.00+26.35%Hold
PHH$13.71N/AN/A
EWCZ$3.22$5.20+61.49%Hold
YSG$4.08N/AN/A
ACU$40.89N/AN/A
View Top Household & Personal Product Stocks

Nu Skin Enterprises Stock Forecast FAQ

Is Nu Skin Enterprises Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: NUS) stock is to Hold NUS stock.

Out of 1 analyst, 0 (0%) are recommending NUS as a Strong Buy, 0 (0%) are recommending NUS as a Buy, 1 (100%) are recommending NUS as a Hold, 0 (0%) are recommending NUS as a Sell, and 0 (0%) are recommending NUS as a Strong Sell.

If you're new to stock investing, here's how to buy Nu Skin Enterprises stock.

What is NUS's earnings growth forecast for 2025-2026?

(NYSE: NUS) Nu Skin Enterprises's forecast annual earnings growth rate of N/A is not forecast to beat the US Household & Personal Products industry's average forecast earnings growth rate of 15.47%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 72.53%.

Nu Skin Enterprises's earnings in 2025 is -$146,594,000.On average, 1 Wall Street analyst forecast NUS's earnings for 2025 to be $54,695,057, with the lowest NUS earnings forecast at $44,750,501, and the highest NUS earnings forecast at $64,639,613.

In 2026, NUS is forecast to generate $37,292,084 in earnings, with the lowest earnings forecast at $37,292,084 and the highest earnings forecast at $37,292,084.

What is NUS's revenue growth forecast for 2025-2026?

(NYSE: NUS) Nu Skin Enterprises's forecast annual revenue growth rate of -7.41% is not forecast to beat the US Household & Personal Products industry's average forecast revenue growth rate of 1.09%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.64%.

Nu Skin Enterprises's revenue in 2025 is $1,732,084,000.On average, 1 Wall Street analysts forecast NUS's revenue for 2025 to be $79,745,392,960, with the lowest NUS revenue forecast at $79,745,392,960, and the highest NUS revenue forecast at $79,745,392,960.

In 2026, NUS is forecast to generate $82,485,118,083 in revenue, with the lowest revenue forecast at $82,485,118,083 and the highest revenue forecast at $82,485,118,083.

What is NUS's forecast return on assets (ROA) for 2025-2026?

(NYSE: NUS) forecast ROA is 2.54%, which is lower than the forecast US Household & Personal Products industry average of 13.64%.

What is NUS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NUS price target, the average NUS price target is $7.00, with the highest NUS stock price forecast at $7.00 and the lowest NUS stock price forecast at $7.00.

The Wall Street analyst predicted that Nu Skin Enterprises's share price could reach $7.00 by Dec 20, 2025. The average Nu Skin Enterprises stock price prediction forecasts a potential upside of 26.35% from the current NUS share price of $5.54.

What is NUS's Earnings Per Share (EPS) forecast for 2025-2026?

(NYSE: NUS) Nu Skin Enterprises's current Earnings Per Share (EPS) is -$2.95. On average, analysts forecast that NUS's EPS will be $1.10 for 2025, with the lowest EPS forecast at $0.90, and the highest EPS forecast at $1.30. In 2026, NUS's EPS is forecast to hit $0.75 (min: $0.75, max: $0.75).

What is NUS's forecast return on equity (ROE) for 2025-2026?

(NYSE: NUS) forecast ROE is 5.72%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.